Neurological Biomarkers Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Neurological Biomarkers Market: By Type (Metabolomic Biomarkers, Proteomic Biomarkers, Genomic Biomarkers, Imaging Biomarkers, Others), By Application (Alzheimer’s, Autism Spectrum Disorder and Parkinson’s, Multiple Sclerosis), By End-use (Clinical Diagnostic Centers, Hospital Laboratories, Research Organizations, Others)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Neurological Biomarkers Market size was valued at USD 7 billion in 2021 and expected to reach a value of USD 16 billion by 2028, at a CAGR of 12.9% during the forecast period 2022- 2028. The global neurological biomarkers market is anticipated to record fast growth with the current neurological disorder conditions all across the world. A huge percentage of people are affected by neurological disorders and consequently causing major disabilities around the world. Because of the increasing cases of neurological disorders, demand for biomarkers is increased for measuring biological states. These biomarkers are also utilized for indication of biological and pathogenic process in terms of healing intervention. They are also used in combination to know the illness state of the person. Biomarkers are also used for those who are suffering from acute ischemic stroke, subarachnoid hemorrhage, and brain injury and intracerebral hemorrhage. The recovery of the patients is totally depending on their mitigation. In such type of situation, a delay can be there in proper examination of the patients due to the complexities. This situation calls for the use of biomarkers and promotes the biomarkers market. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

Neurological Biomarkers Market

MARKET SUMMARY
-
14.5% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 14.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Neurological Biomarkers Market

  • The report on the global Neurological Biomarkers Market gives historical, current, and future market sizes (US$ Bn) on the basis of application, type, end use and region.
  • Global Neurological Biomarkers Market gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Abbott Laboratories
  • Myriad Rbm, Inc
  • Athena Diagnostics
  • Immunarray Pvt. Ltd
  • Acumen Pharmaceuticals Inc
  • Banyan Biomarkers Inc
Drivers And Restraints

Neurological Biomarkers Market

The global neurological biomarkers market is expected to witness a rapid growth with the prevailing neurological disorder cases all over the world. A major percentage of world population is affected by neurological disorders; this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual. Urge in research proposals enables neurological biomarkers market to remain active. Increasing demand for personalized medicine to treat neurological disorders also boom the market growth. Another market driving factor is growing demand for non-invasive diagnostic methods for Parkinson’s and Alzheimer’s. Increasing demand for genomics biomarker will also impel the market growth. On the other hand, strict government rules will hinder the market growth. Emerging legal problems with early identification of Alzheimer’s and Parkinson’s illnesses can also be a restricting factor for the market growth.


North-America got significant share

Neurological Biomarkers Market

Because of the several remarkable players operating in the North America, this region is anticipated to record a huge market share as compared to other regions. Another crucial reason behind booming the market in this region is several research and development projects are carried out in different areas of this region. Academic universities also got enough fund offered by the government for undertaking research. Asia Pacific comes on second number, which also witnesses the huge market revenue share due to the huge population and growing incidental cases of neurological abnormalities in the region. A few other market growing factors in this region are increasing numbers of aged population and entry of new key players in the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Segmentation

Neurological Biomarkers Market


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Abbott Laboratories
  • Myriad Rbm, Inc
  • Athena Diagnostics
  • Immunarray Pvt. Ltd
  • Acumen Pharmaceuticals Inc
  • Banyan Biomarkers Inc

Description

Neurological Biomarkers Market size was valued at USD 7 billion in 2021 and expected to reach a value of USD 16 billion by 2028, at a CAGR of 12.9% during the forecast period 2022- 2028. The global neurological biomarkers market is anticipated to record fast growth with the current neurological disorder conditions all across the world. A huge percentage of people are affected by neurological disorders and consequently causing major disabilities around the world. Because of the increasing cases of neurological disorders, demand for biomarkers is increased for measuring biological states. These biomarkers are also utilized for indication of biological and pathogenic process in terms of healing intervention. They are also used in combination to know the illness state of the person. Biomarkers are also used for those who are suffering from acute ischemic stroke, subarachnoid hemorrhage, and brain injury and intracerebral hemorrhage. The recovery of the patients is totally depending on their mitigation. In such type of situation, a delay can be there in proper examination of the patients due to the complexities. This situation calls for the use of biomarkers and promotes the biomarkers market. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX